United States of America Ex Rel. Harold R. Fine v. Sandia Corporation, a Foreign Corporation, United States of America, Amicus Curiae

70 F.3d 568, 40 Cont. Cas. Fed. 76,877, 1995 U.S. App. LEXIS 32655, 1995 WL 688651
CourtCourt of Appeals for the Tenth Circuit
DecidedNovember 21, 1995
Docket94-2121
StatusPublished
Cited by86 cases

This text of 70 F.3d 568 (United States of America Ex Rel. Harold R. Fine v. Sandia Corporation, a Foreign Corporation, United States of America, Amicus Curiae) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America Ex Rel. Harold R. Fine v. Sandia Corporation, a Foreign Corporation, United States of America, Amicus Curiae, 70 F.3d 568, 40 Cont. Cas. Fed. 76,877, 1995 U.S. App. LEXIS 32655, 1995 WL 688651 (10th Cir. 1995).

Opinion

SEYMOUR, Chief Judge.

Harold R. Fine filed this qui tam action against Sandia Corporation (Sandia), which operates Sandia National Laboratory under a contract with the United States Department of Energy (DOE). Mr. Fine alleges that Sandia misappropriated nuclear waste funds in violation of the Nuclear Waste Policy Act (NWPA). The district court dismissed the action for lack of subject matter jurisdiction. Because we conclude that this action is based in part upon publicly disclosed allegations and transactions and because Mr. Fine was not an original source of that information, we affirm.

I.

Sandia National Laboratory is one of nine multiprogram laboratories owned by the United States government and operated by private or university contractors under the DOE’s administrative oversight. In December 1990, the United States General Accounting Office (GAO) issued a report examining the discretionary research and development (R & D) activities at three of the laboratories, including the Sandia laboratory (GAO report). The report included a section which focused on the “taxing” 1 of nuclear waste funds by two of the laboratories during fiscal years 1988 and 1989. See U.S. General Accounting Office, RCED-91-18, Energy Management Better DOE Controls Needed Over Contractors’ Discretionary R & D Funds 40-41 (December 1990). Concluding that those funds should be used only for research involving the storage and disposal of radioactive waste, the report noted that the Los Alamos and Lawrence Livermore Laboratories had assessed $1 million and $420,000 respectively from the waste fund for their discretionary R & D projects in 1989. Id. The report suggested that it was not the first to discover the practice:

Officials from DOE’s Office of Civilian Radioactive Waste Management are aware of the laboratories’ practice of assessing monies spent at the laboratories for their discretionary R & D activities. An official in [that office] told us that the Office recognizes that assessing monies from the waste fund for discretionary R & D may be a violation of the [NWPA] and referred the issue to the DOE [Inspector General (IG) ] about 2 years ago. According to this official, the IG in turn referred the issue to the DOE General Counsel, who has not yet determined whether the practice is permissible.

Id. at 41. Thus, the report indicates that the DOE knew some of its laboratories were “taxing” nuclear waste funds for use in discretionary research and did not condemn the practice.

A congressional hearing in March 1991 further probed the laboratories’ practice. The Environment, Energy and Natural Resources Subcommittee on Government Operations held a hearing to examine the DOE’s practice of “allowing the contractors that operate its major multiprogram laboratories to withhold funds from authorized research programs and research contracts, and to use such funds for other laboratory activities at the discretion of the contractor.” Review of the Department of Energy’s Discretionary Laboratory Research Funds: Hearing Before the Environment, Energy, and Natural Resources Subcomm. of the House Comm. On Government Operations, 102d Cong., 1st Sess. 1 (1991) (opening statement of Rep. Mike Synar). In his testimony before the subcommittee, Victor S. Rezendes, the GAO Director of Energy Issues, listed two instances where the “taxing” of certain funds violated appropriations restrictions. Id. at 129. He testified that

[o]ne was the Nuclear Waste Policy Act. Basically, that prohibits any tapping into that fund for other than the objectives of establishing a nuclear waste disposal repository and related activities.
*570 And what we found is that that was being charged the same overhead rates as, basically, any other DOE program. And in 1989, for example, that amounted to roughly about $1.5 million.

Id. Although the hearings did not specify specifically that Sandia was “taxing” nuclear waste funds, they did shed further light on the national laboratories’ practice.

At the time of the GAO report and the congressional hearing, Mr. Fine was employed by the DOE’s Office of Inspector General, where his duties included auditing Sandia. Following his retirement in July 1991, he continued to investigate the activities of Sandia and other government contractors. He claims that these post-retirement investigations, including his receipt of an anonymous phone call and his independent confirmation of it, formed the basis of the present complaint.

On April 6, 1992, Mr. Fine filed this qui tam action alleging that Sandia improperly assessed a 2.5% “tax” against nuclear waste funds during fiscal years 1991 and 1992 and used the diverted funds in generic, discretionary R & D activities. Because the NWPA specifically earmarks the funds for research on the storage and disposal of radioactive waste, he asserts that Sandia knowingly presented a false claim to the government when it certified that it had spent the funds in accordance with the applicable rules and regulations.

Mr. Fine filed this action pursuant to 31 U.S.C. § 3730, the qui tam provision of the False Claims Act (FCA). This statute authorizes private individuals, acting on behalf of the government, to bring civil actions against those who defraud the government. To encourage the exposure of fraudulent activities, the FCA allows a successful qui tam plaintiff to receive up to 30% of the final recovery. However, to ensure that individuals cannot use the qui tam provisions to benefit from frauds already exposed through other means, the FCA contains explicit jurisdictional requirements. The statute bars suits which are

based upon the public disclosure of allegations or transactions in a criminal, civil, or administrative hearing, in a congressional, administrative, or [GAO] report, hearing, audit, or investigation, or from the news media, unless ... the person bringing the action is an original source of the information.

Id. § 3730(e)(4)(A). The FCA defines “original source” as “an individual who has direct and independent knowledge of the information on which the allegations are based and has voluntarily provided the information to the Government before filing [a qui tam action] which is based on the information.” Id. § 3730(e)(4)(B).

Applying these requirements, the district court concluded that it did not have jurisdiction over Mr. Fine’s complaint. The court held that the general allegations regarding the laboratories’ “taxing” of nuclear waste funds contained in the 1990 GAO report and the 1991 congressional hearing were sufficient to constitute “public disclosures” of the practice. 2 Although the court held that Mr. Fine’s former employment with the DOE Inspector General did not preclude him from filing a qui tam action, 3

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fiorisce v. Colorado Technical University
130 F.4th 811 (Tenth Circuit, 2025)
Heron v. Nationstar Mortgage
Tenth Circuit, 2024
Rosenberg v. JPMorgan Chase & Co.
Massachusetts Supreme Judicial Court, 2021
U.S. ex rel. Kathi Holloway
960 F.3d 836 (Sixth Circuit, 2020)
United States v. Omnicare, Inc.
903 F.3d 78 (Third Circuit, 2018)
Folliard v. Comstor Corporation
District of Columbia, 2018
United States ex rel. Folliard v. Comstor Corp.
308 F. Supp. 3d 56 (D.C. Circuit, 2018)
U.S. Ex Rel. Mcfarland v. Florida Pharmacy Soln.
358 F. Supp. 3d 1316 (M.D. Florida, 2017)
United States v. CSL Behring, L.L.C.
855 F.3d 935 (Eighth Circuit, 2017)
United States Ex Rel. Mateski v. Raytheon Co.
816 F.3d 565 (Ninth Circuit, 2016)
United States ex rel. Hagerty v. Cyberonics, Inc.
95 F. Supp. 3d 240 (D. Massachusetts, 2015)
United States v. Pfizer, Inc.
9 F. Supp. 3d 34 (D. Massachusetts, 2014)
United States ex rel. Colquitt v. Abbott Laboratories
864 F. Supp. 2d 499 (N.D. Texas, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
70 F.3d 568, 40 Cont. Cas. Fed. 76,877, 1995 U.S. App. LEXIS 32655, 1995 WL 688651, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-harold-r-fine-v-sandia-corporation-a-ca10-1995.